Second Circuit Holds that Criminal Penalties for Pharmaceutical Sales Representative's Off-Label Promotion Violate the First Amendment

December.07.2012

This White Collar & Corporate Investigations alert analyzes a Second Circuit decision set to transform the regulatory landscape in which pharmaceutical and medical device companies operate.